A shortened activated partial thromboplastin time predicts the risk of catheter-associated venous thrombosis in cancer patients

Article ID	Journal	Published Year	Pages	File Type
6000863	Thrombosis Research	2014	4 Pages	PDF

Abstract

Cancer patients undergoing catheter placement who develop CVC-associated VTE have a shorter aPTT and aPTT ratio than those who do not develop VTE. aPTT, a simple and inexpensive test might be useful as a predictor of CVC-associated VTE risk in cancer patients.

Keywords

APTT VTE LETS Venous thromboembolism thrombin-antithrombin computed tomography activated partial thromboplastin time Cancer confidence interval Factor VIII Fibrinogen prothrombin fragment 1.2 C-reactive protein CRP Central venous catheters

Related Topics

Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine

Preview

A shortened activated partial thromboplastin time predicts the risk of catheter-associated venous thrombosis in cancer patients

Authors

Maheswari Senthil, Preeti Chaudhary, David D. Smith, Patrick E. Ventura, Paul H. Frankel, Vinod Pullarkat, Vijay Trisal,